Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3204157 | The Journal of Allergy and Clinical Immunology: In Practice | 2016 | 8 Pages |
Abstract
Systemic treatment controls systemic involvement in EGPA, but not asthma and nasal diseases, which negatively affects patients' quality of life.
Keywords
ANCASino-Nasal Outcome TestACTENTICSnNOEGPAFeNOBVASECPSF-36Asthmaantineutrophil cytoplasmic antibodiesEosinophiliainflammationBirmingham Vasculitis Activity Scorefractional exhaled nitric oxidenasal nitric oxidevasculitisAsthma control testSputumRhinosinusitisNasal cytologyGlobal Initiative for Asthma36-Item Short Form Health SurveyEosinophil cationic proteinCorticosteroidsInhaled corticosteroidsGranulomatosiseosinophilic granulomatosis with polyangiitisGINA
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Manuela MD, Chiara MD, Veronica MD, Pasquale PhD, Federica MD, Alessandro MD, Elena MD, Silvana PhD, Federico L. MD, Stefano MD, Pierluigi MD,